- Home
- CUE vs UONE Comparison
CUE vs UONE Comparison
Compare CUE & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- UONE
- Stock Information
- Founded
- CUE 2014
- UONE 1980
- Country
- CUE United States
- UONE United States
- Employees
- CUE N/A
- UONE N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- UONE Broadcasting
- Sector
- CUE Health Care
- UONE Consumer Discretionary
- Exchange
- CUE Nasdaq
- UONE Nasdaq
- Market Cap
- CUE 59.5M
- UONE 70.8M
- IPO Year
- CUE 2018
- UONE N/A
- Fundamental
- Price
- CUE $0.74
- UONE $1.39
- Analyst Decision
- CUE Strong Buy
- UONE
- Analyst Count
- CUE 2
- UONE 0
- Target Price
- CUE $3.00
- UONE N/A
- AVG Volume (30 Days)
- CUE 116.9K
- UONE 17.7K
- Earning Date
- CUE 08-12-2025
- UONE 11-06-2025
- Dividend Yield
- CUE N/A
- UONE N/A
- EPS Growth
- CUE N/A
- UONE N/A
- EPS
- CUE N/A
- UONE N/A
- Revenue
- CUE $8,286,000.00
- UONE $411,386,000.00
- Revenue This Year
- CUE N/A
- UONE N/A
- Revenue Next Year
- CUE $10.19
- UONE N/A
- P/E Ratio
- CUE N/A
- UONE N/A
- Revenue Growth
- CUE N/A
- UONE N/A
- 52 Week Low
- CUE $0.45
- UONE $1.23
- 52 Week High
- CUE $1.99
- UONE $2.02
- Technical
- Relative Strength Index (RSI)
- CUE 38.09
- UONE 33.71
- Support Level
- CUE $0.77
- UONE $1.38
- Resistance Level
- CUE $0.79
- UONE $1.85
- Average True Range (ATR)
- CUE 0.04
- UONE 0.12
- MACD
- CUE -0.01
- UONE -0.02
- Stochastic Oscillator
- CUE 12.87
- UONE 2.77
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.